Author:
Brown A.T,Arthur M.C,Nix J.S,Montgomery J.A,Skinner R.D,Roberson P.K,Borrelli Michael,Culp W.C
Abstract
Background:
Dodecafluoropentane emulsion (DDFPe), given IV one hour after stroke, has been shown to greatly reduce the percent stroke volume (%SV) in rabbits. With repeated doses its effect continued for 24 hours.
Purpose:
Test DDFPe as neuroprotective agent in permanent occlusion rat stroke models in Sprague Dawley (SD) and Spontaneously Hypertensive Rats (SHR) measuring both %SV and neurological assessment scores (NAS).
Methods:
The male rats received either saline (control), or one or four doses (1x or 4x) of DDFPe (0.6ml/kg IV) one hour post stroke. Treatment groups were SD (n=26) (control, 1x and 4x; n=12, 7 and 7) and SHR (n=14) (control, 1x and 4x; n=7, 3 and 4). The 4x doses were given at 1.5 hour intervals. At six hours post stroke, the rats received a NAS using standard tests for balance, reflexes, and motor performance. Then rats were euthanized and brains removed for TTC evaluation of %SV.
Results:
For %SV analysis strain differences were not significant therefore strains were combined. DDFPe significantly decreased %SV in 1x and 4xDDFPe groups compared to control groups (2.59±1.81 and 0.98±0.88 vs. 9.24±6.06, p≤0.001 each; p≤0.0001 for the overall test for treatment effect). The 1x versus 4xDDFPe groups were not significantly different (p=0.40). In NAS analysis both strains showed significant improvement with 4xDDFPe therapy vs. controls, (SD: 5.00+2.45 vs. 9.36+3.56, p=0.01; SHR: 7.75+4.43 vs. 12.14+3.08, p=0.05). Differences between the 1x DDFPe group and controls were not significant (SD: 8.43+3.69; SHR: 9. 33+3.51).
Conclusion:
DDFPe treatment provides significant neuroprotection when assessed six hours post stroke.
Publisher
Bentham Science Publishers Ltd.
Subject
Psychiatry and Mental health,Neurology (clinical),Neurology
Reference20 articles.
1. Ferris A, Robertson R, Fabunmi R, Mosca L.
American heart association and american stroke association national survey of stroke awareness among women.
Circulation
2005;
111
: 1321-26.
2. Go A, Mozaffarian D, Roger V , et al.
Heart Disease and Stroke Statistics - 2014 Update A Report from the American Heart Association.
Circulation Online December 18 2013 Print ISSN 0009-7322 Online ISSN 1524-4539
3. Xavier R, Qureshi A, Kirmani J, Yahia A, Bakshi R.
Neuroimaging of stroke.
South Med J
2003;
96
: 367-69.
4. Johnson JLH, Dolezal MC, Kerschen A, Matsunaga TO, Unger EC.
In vitro comparison of dodecafluoropentane (DDFP), perfluorodecalin (PFD), and perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange.
Artif Cell Blood Substit
2009;
37
: 156-62.
5. Riess JG.
Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery.
Artif Cell Blood Substit
2005;
33
: 47-63.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献